Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

COMT inhibitor disclosed by Roche

June 21, 1996

Pierre Fabre describes 5-HT1 receptor ligands

June 21, 1996

Calcium receptor modulators from NPS Pharm.

June 21, 1996

Universidad de Salamanca reveals LL-15

June 21, 1996

Breast/prostate cancer treatment agents reported

June 21, 1996

LHRH antagonists disclosed by Takeda

June 21, 1996

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...